LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Neratinib
0.00043333
17.28 27.76 8 838 0.0095 -0.2235
MN20160318_Q01
I14
MCF 10A-H2B-mCherry Neratinib
0.00043333
17.28 27.76 1326 838 1.5810 1.1953
MN20160318_Q01
I14
MCF 10A-H2B-mCherry Neratinib
0.00043333
17.28 27.76 1223 838 1.4582 1.1595
MN20160318_Q01
L07
MCF 10A-H2B-mCherry Neratinib
0.00043333
17.28 27.76 1425 838 1.6990 1.2276
MN20160318_Q01
L07
MCF 10A-H2B-mCherry Neratinib
0.00043333
18.98 27.76 10 941 0.0106 -0.1820
MN20160318_Q01
I14
MCF 10A-H2B-mCherry Neratinib
0.00043333
18.98 27.76 1430 941 1.5194 1.1716
MN20160318_Q01
I14
MCF 10A-H2B-mCherry Neratinib
0.00043333
18.98 27.76 1382 941 1.4684 1.1570
MN20160318_Q01
L07
MCF 10A-H2B-mCherry Neratinib
0.00043333
18.98 27.76 1534 941 1.6299 1.2017
MN20160318_Q01
L07
MCF 10A-H2B-mCherry Neratinib
0.00043333
20.68 27.76 15 1119 0.0134 -0.1090
MN20160318_Q01
I14
MCF 10A-H2B-mCherry Neratinib
0.00043333
20.68 27.76 1568 1119 1.4013 1.1306
MN20160318_Q01
I14
MCF 10A-H2B-mCherry Neratinib
0.00043333
20.68 27.76 1596 1119 1.4263 1.1377
MN20160318_Q01
L07
MCF 10A-H2B-mCherry Neratinib
0.00043333
20.68 27.76 1703 1119 1.5219 1.1639
MN20160318_Q01
L07
MCF 10A-H2B-mCherry Neratinib
0.00043333
22.39 27.76 17 1305 0.0130 -0.0845
MN20160318_Q01
I14
MCF 10A-H2B-mCherry Neratinib
0.00043333
22.39 27.76 1761 1305 1.3487 1.1106
MN20160318_Q01
I14
MCF 10A-H2B-mCherry Neratinib
0.00043333
22.39 27.76 1800 1305 1.3786 1.1190
MN20160318_Q01
L07
MCF 10A-H2B-mCherry Neratinib
0.00043333
22.39 27.76 1881 1305 1.4406 1.1358
MN20160318_Q01
L07
MCF 10A-H2B-mCherry Neratinib
0.00043333
24.09 27.76 32 1461 0.0219 0.0252
MN20160318_Q01
I14
MCF 10A-H2B-mCherry Neratinib
0.00043333
24.09 27.76 1890 1461 1.2931 1.0919
MN20160318_Q01
I14
MCF 10A-H2B-mCherry Neratinib
0.00043333
24.09 27.76 1936 1461 1.3245 1.1008
MN20160318_Q01
L07
MCF 10A-H2B-mCherry Neratinib
0.00043333
24.09 27.76 2008 1461 1.3738 1.1142
MN20160318_Q01
L07
MCF 10A-H2B-mCherry Neratinib
0.00043333
25.79 27.76 39 1605 0.0243 0.0598
MN20160318_Q01
I14
MCF 10A-H2B-mCherry Neratinib
0.00043333
25.79 27.76 2051 1605 1.2778 1.0855
MN20160318_Q01
I14
MCF 10A-H2B-mCherry Neratinib
0.00043333
25.79 27.76 2086 1605 1.2996 1.0916
MN20160318_Q01
L07
MCF 10A-H2B-mCherry Neratinib
0.00043333
25.79 27.76 2140 1605 1.3332 1.1007
MN20160318_Q01
L07
MCF 10A-H2B-mCherry Neratinib
0.00043333
27.49 27.76 50 1723 0.0290 0.1039
MN20160318_Q01
I14